Literature DB >> 18455912

Legal provisions and practice in the management of violent patients. a case vignette study in 16 European countries.

Tilman Steinert1, Peter Lepping.   

Abstract

AIM: To compare the clinical management of typical scenarios by using three case vignettes in a substantial number of European countries.
METHOD: Three case vignettes and an associated questionnaire, filled in and finalised by at least two experts from each country.
RESULTS: Legislation and clinical practice varies widely across the 16 included countries. No specific pattern emerged. Certain practices (intravenous medication, mechanical restraint, net beds and forensic transfers, respectively) only exist in few countries. Legislation for involuntary medication is most restrictive in the Netherlands.
CONCLUSIONS: There is little harmonisation and a lack of consistent standards within and across European countries regarding treatment and management of violent patients.

Entities:  

Mesh:

Year:  2008        PMID: 18455912     DOI: 10.1016/j.eurpsy.2008.03.002

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  29 in total

Review 1.  Incidence of seclusion and restraint in psychiatric hospitals: a literature review and survey of international trends.

Authors:  Tilman Steinert; Peter Lepping; Renate Bernhardsgrütter; Andreas Conca; Trond Hatling; Wim Janssen; Alice Keski-Valkama; Fermin Mayoral; Richard Whittington
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-09-02       Impact factor: 4.328

2.  One-year incidence and prevalence of seclusion: Dutch findings in an international perspective.

Authors:  Eric Noorthoorn; Peter Lepping; Wim Janssen; Adriaan Hoogendoorn; Henk Nijman; Guy Widdershoven; Tilman Steinert
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2015-07-19       Impact factor: 4.328

3.  Mechanical restraint in an emergency department: a consecutive series of 593 cases.

Authors:  Nicolas Beysard; Bertrand Yersin; Pierre-Nicolas Carron
Journal:  Intern Emerg Med       Date:  2017-06-17       Impact factor: 3.397

4.  Long-Term Impact of a Tailored Seclusion Reduction Program: Evidence for Change?

Authors:  Patricia S Mann-Poll; Annet Smit; Eric O Noorthoorn; Wim A Janssen; Bauke Koekkoek; Giel J M Hutschemaekers
Journal:  Psychiatr Q       Date:  2018-09

5.  Opinions of forensic schizophrenia patients on the use of restraints: controversial legislative issues.

Authors:  Branimir Margetić; Branka Aukst Margetić; Dragutin Ivanec
Journal:  Psychiatr Q       Date:  2014-12

6.  Rehospitalization risk of former voluntary and involuntary patients with schizophrenia.

Authors:  Carmen Pfiffner; Tilman Steinert; Reinhold Kilian; Thomas Becker; Karel Frasch; Gerhard Eschweiler; Gerhard Längle; Daniela Croissant; Wiltrud Schepp; Prisca Weiser; Susanne Jaeger
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-05-08       Impact factor: 4.328

7.  Long-term effects of involuntary hospitalization on medication adherence, treatment engagement and perception of coercion.

Authors:  Susanne Jaeger; Carmen Pfiffner; Prisca Weiser; Gerhard Längle; Daniela Croissant; Wiltrud Schepp; Reinhold Kilian; Thomas Becker; Gerhard Eschweiler; Tilman Steinert
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2013-04-19       Impact factor: 4.328

8.  Comparison of restraint data from four countries.

Authors:  Peter Lepping; Barkat Masood; Erich Flammer; Eric O Noorthoorn
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2016-05-04       Impact factor: 4.328

9.  Differences in seclusion rates between admission wards: does patient compilation explain?

Authors:  W A Janssen; E O Noorthoorn; H L I Nijman; L Bowers; A W Hoogendoorn; A Smit; G A M Widdershoven
Journal:  Psychiatr Q       Date:  2013-03

10.  Chemical restraint in routine clinical practice: a report from a general hospital psychiatric ward in Greece.

Authors:  Nikolaos Bilanakis; Georgios Papamichael; Vaios Peritogiannis
Journal:  Ann Gen Psychiatry       Date:  2011-02-24       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.